This week, the Centers for Disease Control and Prevention released new estimates of the syndrome’s toll in the United States, suggesting it affects one in five adults younger than 65 who had COVID, and one in four of those aged 65 and older.
There is one more hurdle: The Centers for Disease Control and Prevention must decide whether to formally recommend the booster for this age group. The CDC’s scientific advisers are scheduled to meet on Thursday.
The U.S. is averaging about 300 COVID-19 deaths per day, compared with a peak of about 3,400 a day in January 2021.
White House COVID-19 coordinator Dr. Ashish Jha issued a dire warning Thursday that the U.S. will be increasingly vulnerable to the coronavirus this fall and winter if Congress doesn’t swiftly approve new funding for more vaccines and treatments.
Memories of patients, staff members and neighbors of Central State Mental Hospital are being compiled for a digital archive.
Experts say testing has dropped by 70% to 90% worldwide from the first quarter to the second quarter this year—the opposite of what they say should be happening with new omicron variants on the rise in places such as the United States and South Africa.
The vaccine was initially considered an important tool in fighting the pandemic because it required only one shot. But the single-dose option proved less effective than two doses of the Pfizer and Moderna vaccines.
Two-and-a-half years after it first spilled into humans, the COVID virus has repeatedly changed its structure and chemistry in ways that confound efforts to bring it fully under control.
The pandemic’s toll is no longer falling almost exclusively on those who chose not to get shots, with vaccine protection waning over time and the elderly and immunocompromised having a harder time dodging increasingly contagious strains.
David Ricks’ lunchtime speech to The Economic Club of Indiana—repeated on social media by those in attendance and reported by IBJ and local TV stations—has reverberated across the state.
Anthony Fauci, President Joe Biden’s chief medical adviser, said the United States was in the “full-blown pandemic phase” in the winter, then entered a period he refers to as the “deceleration” phase. The country is transitioning, he said, to the control phase.
Paxlovid, when administered within five days of symptoms appearing, has been proven to bring about a 90% reduction in hospitalizations and deaths among patients most likely to get severe disease.
Officials are expressing increasing alarm that the U.S. is also losing out on critical opportunities to secure booster doses and new antiviral pills that could help the country maintain its reemerging sense of normalcy.
COVID-19 vaccinations are at a critical juncture as companies test whether new approaches like combination shots or nasal drops can keep up with a mutating coronavirus—even though it’s not clear if changes are needed.
The imaging agent is the six-year-old company’s first commercial launch, following millions of dollars’ worth of research and clinical tests. It was approved by the U.S. Food and Drug Administration in December.
The notice came minutes after the Centers for Disease Control and Prevention asked the Justice Department to appeal the decision handed down by a federal judge in Florida earlier this week.
Indianapolis Mayor Joe Hogsett is experiencing “mild symptoms” and is isolating at home, his office announced Sunday afternoon.
An arbitrator ordered the payments, and the hospitals say they can claim at least another $12 million from Anthem for tens of thousands of additional claims that it says the insurer has downgraded and not paid in full.
Prevounce Health, which launched in 2019 in Los Angeles, relocated its operations to Indianapolis last fall and just landed $4.5 million in investment funding which the company says will help it expand and double its workforce in coming months.
With official reporting of COVID-19 cases and testing data becoming less frequent and less reliable, especially as people test at home, sewage monitoring has gained increasing importance.
